Name of Clinical Trial: 18F- fluoroestradiol (FES) PET/CT for Breast Cancer/NCT04883814 Summary: This phase 2 clinical trial is assessing the clinical value of using 18F- […]
Imaging Trial: 18F- fluoroestradiol (FES) PET/CT for Breast Cancer Read More »
Biomarker (genomic) testing in tissue or liquid biopsy may be useful in identifying genomic mutations that have approved drugs or are being studied in clinical
Biomarker (Genomic) Testing in Metastatic Lobular Breast Cancer Read More »
At this year’s ASCO, several abstracts and posters featuring invasive lobular carcinoma (ILC), also known as lobular breast cancer, were submitted. One study discussed the
Helping Others with Lobular Breast Cancer Many women find the Lobular Breast Cancer Alliance (LBCA) by searching the internet for information about invasive lobular breast
Advocate Chat: Advocacy Through Supporting Others with ILC Read More »
The Lobular Breast Cancer Alliance (LBCA), the Network of Oncology Patient Navigation in West Africa (NOPNWA), and the Amorvard Foundation sponsored a virtual lobular breast
Lobular Breast Cancer Training Held for West African Medical Providers Read More »
Many women with lobular breast cancer who have found their way to the Lobular Breast Cancer Alliance (LBCA) after they were diagnosed want to help
My ILC Story – Jeanine Read More »
THIS SURVEY IS NOW CLOSED. THANK YOU FOR PARTICIPATING. The Lobular Breast Cancer Alliance is conducting a survey to collect information about the experiences of
Opportunity to Participate in Survey on ILC and Imaging Read More »
The International Invasive Lobular Breast Cancer (ILC) Virtual Symposium will take place on June 24-25, 2021, with special patient advocate focused sessions June 23 and
International ILC Virtual Symposium Takes Place June 24-25 Read More »
Name of the Clinical Study: Understanding How CDH1 Germline Mutations Affect Hereditary Lobular Breast Cancer NCT04206891 Eligible patients: Patients who are under 45 years old
IEO TRIAL: CDH1 Genetic Screening in Lobular Breast Cancer Read More »
The ROSALINE Trial is a Phase 2 pre-operative study for people with early-stage invasive lobular carcinoma (ILC), also know as lobular breast cancer. Name of
ROSALINE Trial for Patients with Early-Stage Lobular Breast Cancer Read More »
Many women diagnosed with lobular breast cancer have found their way to the Lobular Breast Cancer Alliance (LBCA). So have many of their friends and
My ILC Story – Susie Read More »
A Conversation About Finding Local Opportunities for Research Advocacy The Lobular Breast Cancer Alliance (LBCA) continues to provide information and tools to help individuals who
Advocate Chat: Local Research Advocacy Read More »
Recruitment for Campaign Is Currently Taking Place The Lobular Breast Cancer Alliance (LBCA) is proud to partner with the Metastatic Breast Cancer Alliance (MBC Alliance)
Tell Your Metastatic ILC Story for Here All Year Campaign Read More »
Watch Our Video and then Read the Annoucement Below Two-Year Invasive Lobular Carcinoma Research Fellowship Is the First Lobular Breast Cancer-Focused Research Fellowship
Many women with lobular breast cancer who have found their way to the Lobular Breast Cancer Alliance (LBCA) after they were diagnosed want to help
My ILC Story – Laurie Read More »
"*" indicates required fields